For instance, up-regulation of miR-125b results in down-regulation of its target i.e., SRY-Box Transcription Factor 30 (SOX30) in malignant lymphomas that can be regarded as a useful biomarker, diagnostically and therapeutically [10]. This evidence concerns the gene SOX30 and lymphoma.